Waiting Time on Dialysis As the Strongest Modifiable Risk Factor for Renal Transplant Outcomes: a Paired Donor Kidney Analysis
Overview
Affiliations
Background: Waiting time on dialysis has been shown to be associated with worse outcomes after living and cadaveric transplantation. To validate and quantify end-stage renal disease (ESRD) time as an independent risk factor for kidney transplantation, we compared the outcome of paired donor kidneys, destined to patients who had ESRD more than 2 years compared to patients who had ESRD less than 6 months.
Methods: We analyzed data available from the U.S. Renal Data System database between 1988 and 1998 by Kaplan-Meier estimates and Cox proportional hazards models to quantify the effect of ESRD time on paired cadaveric kidneys and on all cadaveric kidneys compared to living-donated kidneys.
Results: Five- and 10-year unadjusted graft survival rates were significantly worse in paired kidney recipients who had undergone more than 24 months of dialysis (58% and 29%, respectively) compared to paired kidney recipients who had undergone less than 6 months of dialysis (78% and 63%, respectively; P<0.001 each). Ten-year overall adjusted graft survival for cadaveric transplants was 69% for preemptive transplants versus 39% for transplants after 24 months on dialysis. For living transplants, 10-year overall adjusted graft survival was 75% for preemptive transplants versus 49% for transplants after 24 month on dialysis.
Conclusions: ESRD time is arguably the strongest independent modifiable risk factor for renal transplant outcomes. Part of the advantage of living-donor versus cadaveric-donor transplantation may be explained by waiting time. This effect is dominant enough that a cadaveric renal transplant recipient with an ESRD time less than 6 months has the equivalent graft survival of living donor transplant recipients who wait on dialysis for more than 2 years.
Kizilbash S, Wi C, Roy M, Ryu E, Matas A, Garovic V Transplant Direct. 2024; 11(1):e1734.
PMID: 39703725 PMC: 11658720. DOI: 10.1097/TXD.0000000000001734.
Ethical Issues in Living Donor Kidney Transplantation: An Update from a Psychosocial Perspective.
Martinelli V, Lumer E, Chiappedi M, Politi P, Gregorini M, Rampino T Healthcare (Basel). 2024; 12(18).
PMID: 39337173 PMC: 11431117. DOI: 10.3390/healthcare12181832.
Provision of transplant education for patients starting dialysis: Disparities persist.
Villani V, Bertuzzi L, Butler G, Eliason P, Roberts J, DePasquale N Heliyon. 2024; 10(17):e36542.
PMID: 39281438 PMC: 11399580. DOI: 10.1016/j.heliyon.2024.e36542.
Almeida M, Pereira P, Silvano J, Ribeiro C, Pedroso S, Tafulo S Transpl Int. 2024; 37:13356.
PMID: 39253385 PMC: 11381247. DOI: 10.3389/ti.2024.13356.
Ferreira E, Requiao-Moura L, Nakamura M, Foresto R, Pestana J, Tedesco-Silva H Transplant Direct. 2024; 10(9):e1703.
PMID: 39188532 PMC: 11346849. DOI: 10.1097/TXD.0000000000001703.